Antibiotice S.A. (BVB:ATB)

Antibiotice Ratios and Metrics

Market cap in millions RON. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,410	1,645	1,719	937	380	407
Market Cap Growth	0.96%	-4.30%	83.51%	146.47%	-6.60%	24.69%
Enterprise Value	1,637	1,890	1,811	1,011	462	548
Last Close Price	2.10	2.45	2.54	1.35	0.54	0.58
PE Ratio	27.23	31.77	16.82	11.55	7.38	13.59
Forward PE	-	11.61	11.61	11.61	11.61	11.61
PS Ratio	2.14	2.49	2.50	1.52	0.75	1.07
PB Ratio	1.51	1.77	1.92	1.11	0.51	0.67
P/TBV Ratio	1.56	1.82	1.97	1.12	0.52	0.71
P/FCF Ratio	-	-	-	23.75	4.87	26.44
P/OCF Ratio	19.46	22.71	18.06	7.65	3.29	9.15
EV/Sales Ratio	2.48	2.86	2.63	1.64	0.91	1.45
EV/EBITDA Ratio	13.10	15.12	11.90	8.07	4.84	9.34
EV/EBIT Ratio	23.13	26.71	16.90	10.38	6.34	16.01
EV/FCF Ratio	-23.33	-	-	25.64	5.91	35.63
Debt / Equity Ratio	0.25	0.25	0.16	0.08	0.11	0.24
Debt / EBITDA Ratio	1.90	1.90	0.94	0.55	0.85	2.47
Debt / FCF Ratio	-	-	-	1.75	1.04	9.41
Net Debt / Equity Ratio	0.24	0.24	0.16	0.08	0.11	0.24
Net Debt / EBITDA Ratio	1.82	1.82	0.92	0.54	0.83	2.43
Net Debt / FCF Ratio	-3.24	-3.24	-38.76	1.71	1.01	9.27
Asset Turnover	0.49	0.49	0.57	0.58	0.54	0.43
Inventory Turnover	1.46	1.46	1.53	1.53	1.51	1.37
Quick Ratio	1.27	1.27	1.22	1.24	1.50	1.39
Current Ratio	2.02	2.02	2.02	2.11	2.57	1.93
Return on Equity (ROE)	5.67%	5.67%	11.74%	10.21%	7.65%	5.07%
Return on Assets (ROA)	3.31%	3.31%	5.54%	5.73%	4.84%	2.44%
Return on Invested Capital (ROIC)	5.24%	5.55%	10.90%	9.95%	7.32%	4.57%
Return on Capital Employed (ROCE)	6.20%	6.20%	10.30%	10.30%	8.60%	4.90%
Earnings Yield	3.67%	3.15%	5.95%	8.66%	13.55%	7.36%
FCF Yield	-4.98%	-4.27%	-0.21%	4.21%	20.55%	3.78%
Dividend Yield	1.81%	1.46%	0.81%	6.16%	1.46%	0.56%
Payout Ratio	30.81%	30.81%	47.13%	6.70%	6.66%	7.02%
Total Shareholder Return	1.81%	1.46%	0.81%	6.16%	1.46%	0.56%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.